Results 291 to 300 of about 22,636 (317)
Some of the next articles are maybe not open access.

Effect of biguanides and atromid on fibrinolysis

Journal of Atherosclerosis Research, 1967
Summary The effects of phenformin, metformin, and Atromid on blood fibrinolytic activity, plasma fibrinogen, and serum cholesterol levels were compared in a study of 36 out-patients with occlusive vascular disease. Atromid was the least satisfactory fibrinolytic drug, having only a transient effect on the blood clot lysis time, though a more ...
Elizabeth D. Hocking   +3 more
openaire   +3 more sources

Review of Biguanide (Metformin) Toxicity

Journal of Intensive Care Medicine, 2018
In the 1920s, guanidine, the active component of Galega officinalis, was shown to lower glucose levels and used to synthesize several antidiabetic compounds. Metformin (1,1 dimethylbiguanide) is the most well-known and currently the only marketed biguanide in the United States, United Kingdom, Canada, and Australia for the treatment of non-insulin ...
Christopher Hoyte   +3 more
openaire   +3 more sources

Biguanid-induzierte Laktatazidose

1995
Es gibt Angaben, das das Risiko einer Laktatazidose unter Metformintherapie bei 0,024-0,084 Fallen pro 1000 Patientenjahre lage. Das entspricht 1:11000 bis 1:40 000 der Metformin-behandelten Patienten pro Jahr. Die Mortalitat ist nochmal um den Faktor 3 geringer. Die beschriebenen Todesfalle traten bei Patienten mit Kontraindikationen fur Metformin auf.
openaire   +2 more sources

CHAPTER 17:Antidiabetic Biguanides as Anti-Aging Drugs

, 2017
Evidence has emerged that metformin and other antidiabetic biguabides are promising candidates for pharmacological interventions leading to slowing down of aging, prolonged life span and preventing or postponing age-associate diseases, including cancer ...
V. Anisimov
semanticscholar   +1 more source

Silver(III) biguanides

Journal of the Chemical Society A: Inorganic, Physical, Theoretical, 1969
A series of quadricovalent cationic complexes of silver(III) with biguanide and with methylbiguanide having the composition [AgIIIL2]X3, where L is a bidentate ligand and X a univalent anion, has been prepared and characterised. In alkaline, neutral, and feebly acidic medium (pH > 5), the biguanide molecule possesses filled π-type delocalised orbitals.
openaire   +2 more sources

Environmental Fate of Polyhexamethylene Biguanide

Bulletin of Environmental Contamination and Toxicology, 2011
Polyhexamethylene biguanide (PHMB) is used as a bacteriocidal agent in a variety of applications from medical devices to pools, but is highly toxic to some aquatic species. The stability of PHMB in various environmental matrices was examined. 80% of PHMB was present in fortified creek samples after 20 days, but bound immediately to soils with the ...
openaire   +3 more sources

Clinical Pharmacology of Biguanides

1996
The biguanide drugs have been used to treat hyperglycaemia in non-insulin-dependent diabetes mellitus (NIDDM) for almost 40 years (Sterne 1969; Hermann 1979; Schafer 1983; Bailey 1992). Repeated reports of phenformin-associated lactic acidosis led to the withdrawal of this biguanide in the United States in 1977 and in most other countries.
openaire   +2 more sources

FIBRINOLYTIC EFFECT OF BIGUANIDES

Annals of the New York Academy of Sciences, 1968
R. Chakrabarti   +3 more
openaire   +3 more sources

BIGUANIDE OR DIGUANIDE?

The Lancet, 1961
W.J.H. Butterfield, Ian Murray
openaire   +2 more sources

Home - About - Disclaimer - Privacy